Webinar Registration Form

The European Pharmacopoeia (Ph. Eur.) and the Parenteral Drug Association (PDA) have chapters devoted to the validation of qPCR-based Mycoplasma methods. Nevertheless, there are no clear guidelines, leaving the validation of a qPCR-based Mycoplasma method open to interpretation.

Thermo Fisher Scientific has joined with American Pharmaceutical Review to offer different perspectives on implementing the Applied Biosystems™ MycoSEQ™ Mycoplasma Detection System. In this presentation, Esther van Loon will be covering her experience with the MycoSEQ Mycoplasma Detection Kit in a webinar titled "Development and Validation of a Rapid Hybrid qPCR Mycoplasma Method."

In this webinar we’ll discuss:

Sample treatment in the case of high background signals
Strain selection
Limit of detection

About the presenter

Esther van Loon
Esther van Loon went to Hogeschool Utrecht, where she studied life sciences and specialized in molecular biology. In 2011 she received her BSc degree. After graduation she began working for MSD Oss with the Center of Expertise (CoE) group. She is focusing on developing a rapid, hybrid Mycoplasma method.

Fill in the form to register for the webinar

(*Indicates a mandatory field)

First name*

Last name*

Institution*

City*

Country/Region*

Email*